Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Recro Pharma, Inc. REPH

Set alert

Price alert · REPH

All alert types
2.09 +2.09 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
177.42M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-11.61
Beta
0.00
Short ratio
5.87
Inst. own
54.96%
Dividend
0.00
Ex-div date
Earnings
May 5, 2022
50-d avg
1.73
200-d avg
1.88
1y target
5.00

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for REPH has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.06 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -14.9×
FY 2014: -1.1×FY 2015: 25.0×FY 2016: -2.9×FY 2017: -3.5×FY 2018: -1.8×FY 2019: -23.2×FY 2020: -2.5×FY 2021: -3.3×FY 2022: -6.1×FY 2023: -14.9×
FY 2014 5y median -6.1× FY 2023
P/S 2.1×
FY 2014: 0.0×FY 2015: 1.5×FY 2016: 1.2×FY 2017: 2.5×FY 2018: 1.9×FY 2019: 4.4×FY 2020: 1.0×FY 2021: 1.2×FY 2022: 1.3×FY 2023: 2.1×
FY 2014 5y median 1.3× FY 2023
P/B 3.4×
FY 2014: 0.9×FY 2015: 1.9×FY 2016: 1.2×FY 2017: 6.1×FY 2018: -7.5×FY 2019: -64.5×FY 2020: -4.8×FY 2021: 2.1×FY 2022: 2.0×FY 2023: 3.4×
FY 2014 5y median 2.0× FY 2023
P/FCF -21.5×
FY 2014: -1.6×FY 2015: 12.6×FY 2016: -12.4×FY 2017: -7.4×FY 2018: -2.7×FY 2019: -12.8×FY 2020: 146×FY 2021: 15.8×FY 2022: -10.1×FY 2023: -21.5×
FY 2014 5y median -10.1× FY 2023
EV/EBITDA -16.4×
FY 2014: 0.2×FY 2015: -90.6×FY 2016: -2.6×FY 2017: -5.3×FY 2018: -3.7×FY 2019: 16.0×FY 2020: 749×FY 2021: 14.7×FY 2022: 427×FY 2023: -16.4×
FY 2014 5y median 16.0× FY 2023
EV/Sales 2.5×
FY 2014: 0.0×FY 2015: 1.7×FY 2016: 0.7×FY 2017: 2.4×FY 2018: 2.2×FY 2019: 5.3×FY 2020: 2.3×FY 2021: 2.2×FY 2022: 1.3×FY 2023: 2.5×
FY 2014 5y median 2.3× FY 2023
FCF Yield -4.6%
FY 2014: -60.9%FY 2015: 7.9%FY 2016: -8.1%FY 2017: -13.5%FY 2018: -37.0%FY 2019: -7.8%FY 2020: 0.7%FY 2021: 6.3%FY 2022: -9.9%FY 2023: -4.6%
FY 2014 5y median -4.6% FY 2023

Profitability

Gross Margin 19.2%
FY 2014: 0.0%FY 2015: 46.0%FY 2016: 46.4%FY 2017: 46.8%FY 2018: 44.2%FY 2019: 48.6%FY 2020: 18.6%FY 2021: 26.3%FY 2022: 25.6%FY 2023: 19.2%
FY 2014 5y median 25.6% FY 2023
Operating Margin -3.8%
FY 2014: 0.0%FY 2015: -13.4%FY 2016: -37.2%FY 2017: -56.1%FY 2018: -69.9%FY 2019: 23.8%FY 2020: -12.5%FY 2021: 5.0%FY 2022: -36.4%FY 2023: -3.8%
FY 2014 5y median -3.8% FY 2023
Net Margin -14.0%
FY 2014: 0.0%FY 2015: 5.8%FY 2016: -43.6%FY 2017: -69.7%FY 2018: -103.1%FY 2019: -18.8%FY 2020: -41.4%FY 2021: -35.2%FY 2022: -22.0%FY 2023: -14.0%
FY 2014 5y median -22.0% FY 2023
ROE -22.6%
FY 2014: -85.2%FY 2015: 7.5%FY 2016: -42.2%FY 2017: -173.6%FY 2018: 408.8%FY 2019: 277.6%FY 2020: 195.0%FY 2021: -63.0%FY 2022: -33.2%FY 2023: -22.6%
FY 2014 5y median -22.6% FY 2023
ROIC -2.5%
FY 2014: -62.7%FY 2015: 1.3%FY 2016: -14.7%FY 2017: -28.5%FY 2018: -42.7%FY 2019: 18.8%FY 2020: -8.6%FY 2021: 2.6%FY 2022: -22.9%FY 2023: -2.5%
FY 2014 5y median -2.5% FY 2023
ROA -8.6%
FY 2014: -79.2%FY 2015: 2.2%FY 2016: -16.5%FY 2017: -26.9%FY 2018: -51.3%FY 2019: -16.9%FY 2020: -26.6%FY 2021: -16.5%FY 2022: -12.6%FY 2023: -8.6%
FY 2014 5y median -16.5% FY 2023

Growth (YoY)

Revenue 4.9%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 33.5%FY 2017: 3.6%FY 2018: 7.7%FY 2019: 28.3%FY 2020: -33.0%FY 2021: 13.3%FY 2022: 19.7%FY 2023: 4.9%
FY 2014 FY 2023
Operating Income 89.1%
FY 2014: -989.4%FY 2015: 41.3%FY 2016: -269.8%FY 2017: -56.4%FY 2018: -34.1%FY 2019: 143.7%FY 2020: -135.3%FY 2021: 145.1%FY 2022: -972.3%FY 2023: 89.1%
FY 2014 FY 2023
EPS (diluted) 58.8%
FY 2014: -311.1%FY 2015: 113.5%FY 2016: -905.7%FY 2017: 6.7%FY 2018: -48.3%FY 2019: 79.7%FY 2020: -46.8%FY 2021: 55.2%FY 2022: 34.6%FY 2023: 58.8%
FY 2014 FY 2023
Free Cash Flow 23.0%
FY 2014: -1230.6%FY 2015: 155.6%FY 2016: -215.3%FY 2017: -240.4%FY 2018: -126.4%FY 2019: 37.0%FY 2020: 101.4%FY 2021: 1100.2%FY 2022: -315.4%FY 2023: 23.0%
FY 2014 FY 2023

Financial Health

Current Ratio 1.1×
FY 2014: 14.1×FY 2015: 4.1×FY 2016: 5.2×FY 2017: 1.7×FY 2018: 2.5×FY 2019: 9.3×FY 2020: 6.9×FY 2021: 3.2×FY 2022: 2.4×FY 2023: 1.1×
FY 2014 5y median 3.2× FY 2023
Quick Ratio 0.9×
FY 2014: 14.1×FY 2015: 3.1×FY 2016: 4.7×FY 2017: 1.6×FY 2018: 2.1×FY 2019: 7.0×FY 2020: 5.4×FY 2021: 2.7×FY 2022: 2.0×FY 2023: 0.9×
FY 2014 5y median 2.7× FY 2023
Debt / Equity 0.7×
FY 2014: 0.0×FY 2015: 0.7×FY 2016: 0.3×FY 2017: 2.0×FY 2018: -3.3×FY 2019: -16.5×FY 2020: -7.8×FY 2021: 2.5×FY 2022: 0.2×FY 2023: 0.7×
FY 2014 5y median 0.2× FY 2023
Net Debt / EBITDA -2.4×
FY 2014: 1.7×FY 2015: -10.5×FY 2016: 2.2×FY 2017: 0.1×FY 2018: -0.6×FY 2019: 2.8×FY 2020: 419×FY 2021: 6.9×FY 2022: -6.3×FY 2023: -2.4×
FY 2014 5y median 2.8× FY 2023
Interest Coverage 0.4×
FY 2014: -2.8×FY 2015: -1.3×FY 2016: -4.6×FY 2017: -3.3×FY 2018: -6.2×FY 2019: 1.2×FY 2020: -0.4×FY 2021: 0.2×FY 2022: 2.3×FY 2023: 0.4×
FY 2014 5y median 0.4× FY 2023

Dividends

Dividend Yield 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2014 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31